These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30826910)

  • 1. Hand-held, dilation-free, electroretinography in children under 3 years of age treated with vigabatrin.
    Ji X; McFarlane M; Liu H; Dupuis A; Westall CA
    Doc Ophthalmol; 2019 Jun; 138(3):195-203. PubMed ID: 30826910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of correlation between Diopsys® NOVA™ fixed-luminance flicker ERG and Diagnosys® Espion 2™ flicker ERG parameters.
    Regenold J; Doan HL; Ghoraba H; Khojasteh H; Jaclyn Hwang JJ; Yavari N; Akhavanrezayat A; Than NTT; Le AHD; Halim MS; Nguyen QD
    Doc Ophthalmol; 2023 Jun; 146(3):257-266. PubMed ID: 37219642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the ERG d-wave with vigabatrin treatment in a pediatric cohort.
    Dragas R; Westall C; Wright T
    Doc Ophthalmol; 2014 Oct; 129(2):97-104. PubMed ID: 25008578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of light- and dark-adapted ERGs using a mydriasis-free, portable system: clinical classifications and normative data.
    Liu H; Ji X; Dhaliwal S; Rahman SN; McFarlane M; Tumber A; Locke J; Wright T; Vincent A; Westall C
    Doc Ophthalmol; 2018 Dec; 137(3):169-181. PubMed ID: 30357588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cataracts on flicker electroretinograms recorded with RETeval™ system: new mydriasis-free ERG device.
    Miura G; Nakamura Y; Sato E; Yamamoto S
    BMC Ophthalmol; 2016 Mar; 16():22. PubMed ID: 26944722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroretinogram as a Screening Tool to Assess Vigabatrin-Induced Retinal Toxicity in Children With Infantile Spasms.
    Nagarajan S; Prabu R; Parachuri N; Thulasidas M
    J Pediatr Ophthalmol Strabismus; 2024; 61(4):273-278. PubMed ID: 38482803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full-field ERG and visual fields in patients 5 years after discontinuing vigabatrin therapy.
    Kjellström U; Lövestam-Adrian M; Andréasson S; Ponjavic V
    Doc Ophthalmol; 2008 Sep; 117(2):93-101. PubMed ID: 18188629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cone function by a handheld non-mydriatic flicker electroretinogram device.
    Nakamura N; Fujinami K; Mizuno Y; Noda T; Tsunoda K
    Clin Ophthalmol; 2016; 10():1175-85. PubMed ID: 27445454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vigabatrin effect on inner retinal function.
    Coupland SG; Zackon DH; Leonard BC; Ross TM
    Ophthalmology; 2001 Aug; 108(8):1493-6; discussion 1497-8. PubMed ID: 11470707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological evaluation of retinal function in children receiving vigabatrin medication.
    Kjellström U; Andréasson S; Ponjavic V
    J Pediatr Ophthalmol Strabismus; 2011; 48(6):357-65. PubMed ID: 21261244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal ERG and full-field ERG in patients on long-term vigabatrin medication.
    Ponjavic V; Andréasson S
    Doc Ophthalmol; 2001 Jan; 102(1):63-72. PubMed ID: 11475366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing nonsedated handheld cone flicker electroretingram as a screening test in pediatric patients: comparison to sedated conventional cone flicker electroretinogram.
    Osigian CJ; Grace SF; Cavuoto KM; Feuer WJ; Tavakoli M; Saksiriwutto P; Liu M; Capo H; Lam BL
    J AAPOS; 2019 Feb; 23(1):34.e1-34.e5. PubMed ID: 30625363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the electroretinogram resulting from discontinuation of vigabatrin in children.
    Westall CA; Nobile R; Morong S; Buncic JR; Logan WJ; Panton CM
    Doc Ophthalmol; 2003 Nov; 107(3):299-309. PubMed ID: 14711162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study.
    Westall CA; Wright T; Cortese F; Kumarappah A; Snead OC; Buncic JR
    Neurology; 2014 Dec; 83(24):2262-8. PubMed ID: 25381295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hospital for Sick Children, Toronto, Longitudinal ERG study of children on vigabatrin.
    Westall CA; Logan WJ; Smith K; Buncic JR; Panton CM; Abdolell M
    Doc Ophthalmol; 2002 Mar; 104(2):133-49. PubMed ID: 11999622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric norms for photopic electroretinogram testing based on a large cohort of Chinese preschool children.
    Chan SS; Choi KY; Chan HH
    BMJ Open Ophthalmol; 2024 Feb; 9(1):. PubMed ID: 38388004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field-specific visual-evoked potentials: identifying field defects in vigabatrin-treated children.
    Harding GF; Spencer EL; Wild JM; Conway M; Bohn RL
    Neurology; 2002 Apr; 58(8):1261-5. PubMed ID: 11971096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flicker electroretinogram recorded with portable ERG device in prematurely born schoolchildren with and without ROP.
    Tekavčič Pompe M; Šuštar M
    Doc Ophthalmol; 2019 Aug; 139(1):59-65. PubMed ID: 30972611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
    Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
    Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining visual field defects in the paediatric population exposed to vigabatrin.
    Spencer EL; Harding GF
    Doc Ophthalmol; 2003 Nov; 107(3):281-7. PubMed ID: 14711160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.